News
AB SCIEX is a global leader in mass spectrometry technologies, building on a more than 20-year history of innovation in the most promising field to push the limits in clinical research and forensics: ...
Dr. Binz’s lab has been aiding forensic investigations for over a decade and plays a key role in the Swiss criminal justice ...
SCIEX’s Reveals How They're Setting New Standards in Mass Spectrometry at SLAS 2024.
FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced today the launch of ...
SCIEX today announced their latest solution in the X-Series Quadrupole Time of Flight (QTOF) mass spectrometry (MS) platform, the X500B QTOF System.
This agreement allows users to access SCIEX mass spectrometry systems and the Evosep Eno via a single product catalogue issued by SCIEX.
AB SCIEX, a global leader in analytical technologies, today unveiled three new solutions for biological researchers to improve identification and quantitation of proteins, peptides, metabolites ...
Seer Proteograph™ Product Suite combined with SCIEX mass spectrometry technology to provide unbiased, deep proteomics workflows for labs of all typesREDWOOD CITY, Calif., March 29, 2021 (GLOBE ...
This approach is focused on advancements in protein identification and quantification and is made possible by new-generation AB SCIEX mass spectrometry technology and Eksigent chip-based nanoLC ...
Although mass spec isn’t inherently quantitative, it is putting numbers to the proteome and making ever-finer distinctions in process monitoring and quality control.
The Institute of Cancer Research (ICR) is working with AB Sciex to standardize advanced methods of mass spectrometry-based tissue imaging. ICR’s research into cancer metastasis focuses on ...
AB SCIEX and Indigo BioSystems have entered into a collaboration to jointly market mass spectrometry solutions that simplifies LC/MS/MS workflows.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results